Become A Partner

The MRS is eager to work with and support others who share our mission. We are open to partnership with organizations associated with any cancer type in any country that have a particular interest in improving outcomes for metastatic cancer patients and metastatic cancer research.  If you or your organization is interested in partnering with the society please contact us at  We also have many opportunities for individual or company sponsors listed here.


Current Partners

METAvivor Research and Support Inc., USA

In 2015, the MRS entered into a Strategic Partnership for Metastatic Cancer Research with METAvivor Research and Support Inc.  METAvivor is a non-profit organization in the US that uses 100% of donations to fund metastatic breast cancer research specifically.  They also have strong advocacy efforts and offer peer-to-peer support.
The Strategic Partnership began with the goal of improving metastatic breast cancer patient outcomes by educating metastatic breast cancer patients about cancer metastasis research. In 2017, we expanded upon this goal.  We now also strive to create projects that engage patients with metastatic cancer researchers and oncologists together in the design and conduct of patient-centered metastasis research and hope to strengthen and expand patient/researcher/clinician relationships.  Our efforts are designed to support informed metastatic patient treatment decisions and generate a clear understanding of the needs of the metastatic patient in the clinical setting.

Participation in the Strategic Partnership for Metastatic Cancer Research is open to other groups who are “In it for LIFE,” the Alliance’s mantra which represents the patient advocates and researchers whose primary focus is on active metastasis research that will benefit patients who are living with a metastasized cancer of any kind.


Metastatic Breast Cancer Alliance (MBCA), USA

The MRS is an official member of the Metastatic Breast Cancer Alliance.  This is a patient-led group of members with collaborative initiatives in metastatic breast cancer lab research, clinical trials, epidemiology, education and access, and awareness.


Become a partner! Email us today: